BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Hematopoietic cell, Fluoxetine, rs2300478, FXYD4, glucose metabolic process)
Bookmark Forward

QuickView for CXCR4;jsessionid=189F88D0448206D09B02DE014A2BA1A8;jsessionid=2E5DCC168D5C7B09DD2A93473988DDE4;jsessionid=99F88035DF859F495A657B7C7DF141EA;jsessionid=8539B46248EC3F494BE71D9160A51FD0 (gene)


Body Atlas

Most Correlated Tissues

  1. Eosinophil of peripheral blood
  2. Leukocyte (polymorphonuclear) of peripheral blood
  3. Basophil of peripheral blood
  4. B lymphocyte (naive) of spleen
  5. Neutrophil of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Caseating tuberculoid granuloma
  2. Chronic fatigue syndrome
  3. Severe combined immunodeficiency disease
  4. Hutchinson-Gilford syndrome
  5. Disorder of neutrophils
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. GDF11 protein, human
  2. R 406 cpd
  3. Cyclic guanosine monophosphate-adenosine monophosphate
  4. Carbonyl Cyanide m-Chlorophenyl Hydrazone
  5. activin A
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ras
  2. HDAC11
  3. KIF2C
  4. ZNF217
  5. HIST1H1B
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. CXCR4 and Glioblastoma.
  2. CXCR4 Ligands: The Next Big Hit?
  3. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
  4. Nuclear Respiratory Factor-1 (NRF-1) Regulates Transcription of the CXC Receptor 4 (CXCR4) in the Ra…
  5. CXCR4 signaling in health and disease.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for CXCR4;jsessionid=189F88D0448206D09B02DE014A2BA1A8;jsessionid=2E5DCC168D5C7B09DD2A93473988DDE4;jsessionid=99F88035DF859F495A657B7C7DF141EA;jsessionid=8539B46248EC3F494BE71D9160A51FD0
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.